Abby R Rosenberg MD MS, MA
Associate Professor, Pediatrics, Harvard Medical School
Join to View Full Profile
450 Brookline Ave# JFB7Boston, MA 02215
Phone+1 617-632-3000
Dr. Rosenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Abby Rosenberg, MD is a Boston-based Pediatric Hematologist/Oncologist with an extensive medical background which includes a fellowship in Pediatric Hematology/Oncology from University of Washington, and a 2006 Residency in Pediatrics from the same institution. She is currently serving as Chief at Dana-Farber Cancer Institute, Director at Boston Children's Hospital, and as Associate Professor at Harvard Medical School from 2022 onward. Prior to these roles, she was employed at Seattle Children's Hospital and was an Attending Physician at Childrens University Medical Group. Dr. Rosenberg's research and expertise has been shared through multiple published works on pediatric oncology and she actively leads multiple clinical trials focusing on resilience in stressed pediatric cancer patients.
Education & Training
- University of WashingtonResidency, Pediatrics, 2006 - 2009
- Stanford University School of MedicineClass of 2006
- University of WashingtonFellowship, Pediatric Hematology/Oncology
Certifications & Licensure
- MA State Medical License 2022 - 2025
- WA State Medical License 2009 - 2024
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors Start of enrollment: 2013 Dec 01
- A Pilot RCT of the PRISM Intervention for AYAs With Cancer Start of enrollment: 2015 Jan 30
- PRISM for Parents of Children With Cancer Promoting Resilience in Stress Management (PRISM) Intervention for Parents of Children With Cancer Start of enrollment: 2016 Dec 05
- Join now to see all
Publications & Presentations
PubMed
- A Qualitative Study of CMC Caregivers' Perspectives about their Emotional Well-Being.Justin A Yu, Amy Porter, Jori Bogetz, Mikhaila Layshock, Lydia McLachlan
Journal of Pain and Symptom Management. 2025-04-03 - A photo-narrative intervention protocol for clinicians and parents of children with severe neurological impairment in the PICU.Jori Bogetz, Elsa Ayala, Jordan Anderson, Liz Morris, Krysta S Barton
Contemporary Clinical Trials Communications. 2025-04-01 - Optimization of a digital health intervention to enhance well-being among adolescent and young adult cancer survivors: Design and methods of the EMPOWER full factorial...John M Salsman, Karly M Murphy, Elizabeth L Addington, Janet A Tooze, Laurie E McLouth
Contemporary Clinical Trials. 2025-02-01
Lectures
- Novel Approaches to Enhance the Educational Process and Improve Patient EngagementASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- Hope and benefit-finding among adolescents and young adults with cancer: Results from the PRISM randomized controlled trial.2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Press Mentions
- Leader in Pediatric Oncology Receives National Honor from American Cancer SocietyJune 30th, 2022
- We, TooApril 28th, 2019
- When Young People Survive Cancer, Their Mental-Health Struggles Are Often Just BeginningJune 29th, 2023
Grant Support
- Collaborative Care to Improve Resilience and Quality of Life among Youth with Non-malignant Blood DisordersDANA-FARBER CANCER INST2024–2029
- Collaborative Care to Improve Resilience and Quality of Life among Youth with Non-malignant Blood DisordersDANA-FARBER CANCER INST2024–2029
- Collaborative Care to Improve Resilience and Quality of Life among Youth with Non-malignant Blood DisordersDANA-FARBER CANCER INST2024–2029
- Collaborative Care to Improve Resilience and Quality of Life among Youth with Non-malignant Blood DisordersDANA-FARBER CANCER INST2024–2029
- Novel Health Equity Intervention to Improve Pediatric Oncology Outcome Disparities: Targeting Poverty and Psychosocial StressDANA-FARBER CANCER INST2022–2028
- Promoting Resilience in Early Survivorship among Adolescents and Young Adults with CancerDANA-FARBER CANCER INST2022–2027
- The Promoting Resilience in Stress Management (PRISM) Intervention: a multi-site randomized controlled trial for Adolescents and Young Adults with advanced cancerDANA-FARBER CANCER INST2023–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: